Display options
Cite
Rao S, Lam MH, Wing YK, et al. Beneficial effect of phosphatidylcholine supplementation in alleviation of hypomania and insomnia in a Chinese bipolar hypomanic boy and a possible explanation to the effect at the genetic level. Springerplus. 2015;4:235doi: 10.1186/s40064-015-1002-y.
Rao, S., Lam, M. H., Wing, Y. K., Yim, L. C., Chu, W. C., Yeung, V. S., & Waye, M. M. (2015). Beneficial effect of phosphatidylcholine supplementation in alleviation of hypomania and insomnia in a Chinese bipolar hypomanic boy and a possible explanation to the effect at the genetic level. SpringerPlus, 4235. https://doi.org/10.1186/s40064-015-1002-y
Rao, Shitao, et al. "Beneficial effect of phosphatidylcholine supplementation in alleviation of hypomania and insomnia in a Chinese bipolar hypomanic boy and a possible explanation to the effect at the genetic level." SpringerPlus vol. 4 (2015): 235. doi: https://doi.org/10.1186/s40064-015-1002-y
Rao S, Lam MH, Wing YK, Yim LC, Chu WC, Yeung VS, Waye MM. Beneficial effect of phosphatidylcholine supplementation in alleviation of hypomania and insomnia in a Chinese bipolar hypomanic boy and a possible explanation to the effect at the genetic level. Springerplus. 2015 May 20;4:235. doi: 10.1186/s40064-015-1002-y. eCollection 2015. PMID: 26120503; PMCID: PMC4476977.
Copy Download .nbib Format: NLM
Share it on

Springerplus. 2015 May 20;4:235. doi: 10.1186/s40064-015-1002-y. eCollection 2015.

Beneficial effect of phosphatidylcholine supplementation in alleviation of hypomania and insomnia in a Chinese bipolar hypomanic boy and a possible explanation to the effect at the genetic level.

SpringerPlus

Shitao Rao, Marco H B Lam, Yun Kwok Wing, Larina C L Yim, Winnie C W Chu, Venus S Y Yeung, Mary M Y Waye

Affiliations

  1. Croucher Laboratory for Human Genomics, School of Biomedical Sciences, The Chinese University of Hong Kong, Rm324A, Lo Kwee-Seong Integrated Biomedical Sciences Building, Shatin, N.T. Hong Kong.
  2. Department of Psychiatry, Shatin Hospital, The Chinese University of Hong Kong, 33 Ah Kong Kok Street, Shatin, N.T. Hong Kong.
  3. Department of Imaging and Interventional Radiology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, N.T. Hong Kong.

PMID: 26120503 PMCID: PMC4476977 DOI: 10.1186/s40064-015-1002-y

Abstract

INTRODUCTION: Recent studies indicated that supplementation of phosphatidylcholine has been found to be beneficial for psychiatric diseases and Diacylglycerol Kinase, Eta (DGKH) protein was involved in regulating the metabolism of phosphatidic acid and diacylglycerol. This study reported a case of a 16-year-old Chinese boy with bipolar hypomania symptoms receiving supplementation of phosphatidylcholine, and a genetic study of a risk variant of DGKH gene was performed in an attempt to provide an explanation for the potential beneficial effect of phosphatidylcholine supplementation.

CASE DESCRIPTION: We described a case of a 16-year-old boy with bipolar disorder, who suffered from monthly episodes of insomnia accompanied by hypomania for 5 months despite adherence to medication. After supplementation of phosphatidylcholine, he returned to a normal sleeping pattern and recovered from hypomania symptoms for approximately 14 months. Furthermore, genotyping results showed that this boy carries the risk genotype (G/C) in DGKH variant rs77072822 (adjusted p-value = 0.025 after 2000 permutation tests).

DISCUSSION AND EVALUATION: The 16-year-old boy appears to have benefited from the supplementation with phosphatidylcholine and recovered from hypomania symptoms. He carries a risk genotype in rs77072822 which lies in the first intron of DGKH gene that was mostly reported to be associated with bipolar disorder. Thus, this finding is consistent with the hypothesis that alleviating the phosphatidylcholine deficiencies might accompany with the risk variants of DGKH gene, which might improve the efficacies of such supplementation and design new treatment strategies for bipolar disorder.

CONCLUSIONS: This study illustrated that a 16-year-old boy with hypomania symptoms responded well to supplementation of phosphatidylcholine and the boy carries a risk genotype in DGKH gene for bipolar disorder, which provides a possible explanation for the boy's beneficial effect at the genetic level.

Keywords: Bipolar hypomania; Diacylglycerol kinase eta (DGKH); Metabolism of diacylglycerol; Phosphatidylcholine supplementation; Susceptibility polymorphism

References

  1. Mol Psychiatry. 2011 May;16(5):473-5 - PubMed
  2. Am J Hum Genet. 2005 May;76(5):887-93 - PubMed
  3. Neuropsychopharmacology. 2013 Feb;38(3):492-503 - PubMed
  4. JAMA. 1989 Oct 6;262(13):1834-41 - PubMed
  5. Am J Hum Genet. 2006 Jun;78(6):1094-5; author reply 1096 - PubMed
  6. Hum Hered. 2008;66(2):87-98 - PubMed
  7. Am J Psychiatry. 1982 Sep;139(9):1162-4 - PubMed
  8. Science. 2013 May 31;340(6136):1051-2 - PubMed
  9. Bioinformatics. 2005 Jan 15;21(2):263-5 - PubMed
  10. Front Genet. 2012 May 31;3:91 - PubMed
  11. Am J Psychiatry. 1982 Jan;139(1):108-10 - PubMed
  12. Am J Psychiatry. 2013 Mar;170(3):290-8 - PubMed
  13. Mol Psychiatry. 2008 Feb;13(2):197-207 - PubMed
  14. PLoS One. 2014 Dec 22;9(12):e115221 - PubMed

Publication Types